| Drug Name |
Cefprozil |
| Drug ID |
BADD_D00397 |
| Description |
Cefprozil is a cephalosporin antibiotic that is commonly employed to treat a variety of bacterial infections, including those of the ear and skin, bronchitis, and others. |
| Indications and Usage |
For the treatment of the following infections (respiratory, skin, soft tissue, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph |
| Marketing Status |
approved |
| ATC Code |
J01DC10 |
| DrugBank ID |
DB01150
|
| KEGG ID |
D00261; D07651
|
| MeSH ID |
C052018
|
| PubChem ID |
5281006
|
| TTD Drug ID |
D0YX4S
|
| NDC Product Code |
82608-009; 65862-100; 57297-400; 16714-399; 68180-403; 65862-069; 16714-397; 50090-1710; 57237-034; 68180-401; 68180-404; 57237-035; 0093-1077; 57237-036; 61788-4000; 65862-068; 65862-378; 0093-1078; 68180-402; 16714-398; 16714-396; 65862-099; 67296-1180; 57237-037 |
| UNII |
4W0459ZA4V
|
| Synonyms |
cefprozil | BMY 28100 | BMY-28100 | 7-(2-amino-2-(p-hydroxyphenyl)acetamido)-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | cefprozil monohydrate | 7-(2-amino-2-(4-hydroxyphenyl)acetamido)-3-(propenyl)-3-cephem-4-carboxylic acid monohydrate | Cefzil | Procef | Arzimol | Brisoral |
